Navifus Corporation
Clinical trials sponsored by Navifus Corporation, explained in plain language.
-
Sound waves may help deliver brain tumor drug
Disease control CompletedThis pilot study tested a device called NaviFUS that uses focused ultrasound to temporarily open the blood-brain barrier, combined with the drug bevacizumab (Avastin), in 6 patients with recurrent glioblastoma (a type of brain cancer). The goal was to see if the combination is sa…
Phase: NA • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Sound waves + radiation: new hope for tough brain tumors?
Disease control CompletedThis small pilot study tested whether combining focused ultrasound with a second round of radiation is safe for people with recurrent glioblastoma, an aggressive brain cancer. Seven adults who had already tried standard treatments received the combination therapy. The goal was to…
Phase: NA • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New ultrasound device shows promise for Tough-to-Treat epilepsy
Symptom relief CompletedThis study tested a device called NaviFUS™ that uses focused ultrasound to calm overactive brain areas in people with drug-resistant epilepsy. Twelve adults whose seizures were not controlled by medication received the treatment. The main goals were to check safety and see if sei…
Phase: NA • Sponsor: NaviFUS Corporation • Aim: Symptom relief
Last updated Jun 22, 2026 12:03 UTC